¥ 8114
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Strong growth
About
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on
Target Price
The average target price of 4578.T is 9025 and suggests 14% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio
